8-K - Aptevo Therapeutics Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Securities Issuance

Other Event

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 8, 2026, Aptevo Therapeutics Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “

Material Agreement

$60.0M$25.0K

Source Document

3.02

Unregistered Sales of Equity Securities. The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. In the Purchase A

Securities Issuance

8.01

of this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Descr

Other Event

Exhibits (3)

10.1

EX-10.1

8-K

99.1

EX-99.1